BMY vs FIVE · P/E 17, rev $48.19B vs P/E 28, rev $1.39B
Bristol-Myers Squibb Company (BMY) versus Five Below Inc (FIVE) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Five Below Inc (FIVE) is a specialty retail company listed on US.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported FIVE revenue for 2025-02-01 was $1.39B. Net income was $187.5M. Revenue was up 64.9% from 2024-11-02 to 2025-02-01. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. FIVE currently screens at market cap $7.30B and trailing P/E 27.7.
Not investment advice. Open the BMY and FIVE stock pages for the full models.
Not investment advice.